Literature DB >> 17646056

Energy balance, insulin resistance biomarkers, and breast cancer risk.

Alecia Malin Fair1, Qi Dai, Xiao-Ou Shu, Charles E Matthews, Herbert Yu, Fan Jin, Yu-Tang Gao, Wei Zheng.   

Abstract

BACKGROUND: American women are five times more likely to be at risk for breast cancer than women from Asian countries. Epidemiologic studies have linked energy balance to an increased risk of breast cancer, yet few studies have investigated potential mediators of this association with Chinese women. We examined the above association by blood levels of insulin-like growth factors (IGFs), binding proteins, and C-peptide in the Shanghai Breast Cancer Study (SBCS), a case-control study conducted among 1,459 breast cancer cases and 1,556 healthy Chinese women from 1996 and 1998.
METHODS: In-person surveys were used to collect data on energy intake, anthropometric measures, exercise/sport activity, and occupational activity. The present analyses consisted of 397 cases and 397 controls whose blood samples were measured for levels of IGFs, insulin growth-factor binding protein 3 (IGFBP-3), C-peptide, and the relationship with physical activity status, total energy intake, and body fat distribution.
RESULTS: Body mass index (BMI) and waist-to-hip ratio (WHR) were significantly positively correlated with IGFBP-3 and C-peptide. Adult exercise/sport activity was significantly negatively correlated with insulin-like growth factor 1 (IGF-I). C-peptide levels increased with increasing quartiles of WHR (p for trend<0.01). Additional analyses were performed to evaluate whether the association of energy balance measures with breast cancer risk changed after adjustment for IGFs, IGFBP-3, and C-peptide biomarkers. The associations attenuated, but none of them changed substantially.
CONCLUSION: Insulin resistance biomarkers may partially explain the association between positive energy balance and breast cancer risk, but future studies are needed to identify the underlying complex biological mechanisms of action for breast cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17646056      PMCID: PMC1994998          DOI: 10.1016/j.cdp.2007.04.003

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  30 in total

1.  Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors.

Authors:  Melinda L Irwin; Anne McTiernan; Leslie Bernstein; Frank D Gilliland; Richard Baumgartner; Kathy Baumgartner; Rachel Ballard-Barbash
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

2.  Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study.

Authors:  H Jernström; E Barrett-Connor
Journal:  J Womens Health Gend Based Med       Date:  1999-12

Review 3.  Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications.

Authors:  C J Rosen
Journal:  Clin Chem       Date:  1999-08       Impact factor: 8.327

4.  Influence of physical activity on plasma insulin-like growth factor-1 and insulin-like growth factor binding proteins in healthy older women.

Authors:  S G Chadan; R P Dill; K Vanderhoek; W S Parkhouse
Journal:  Mech Ageing Dev       Date:  1999-06-01       Impact factor: 5.432

5.  Energy balance and breast cancer risk.

Authors:  Alecia Malin; Charles E Matthews; Xiao-Ou Shu; Hui Cai; Qi Dai; Fan Jin; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-06       Impact factor: 4.254

6.  Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women's Health Study.

Authors:  X O Shu; G Yang; F Jin; D Liu; L Kushi; W Wen; Y-T Gao; W Zheng
Journal:  Eur J Clin Nutr       Date:  2004-01       Impact factor: 4.016

7.  Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma.

Authors:  Alecia Malin; Qi Dai; Herbert Yu; Xiao-Ou Shu; Fan Jin; Yu-Tang Gao; Wei Zheng
Journal:  Cancer       Date:  2004-02-15       Impact factor: 6.860

Review 8.  Insulin-like growth factors and cancer.

Authors:  V M Macaulay
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

Review 9.  Breast cancer: further metabolic-endocrine risk markers?

Authors:  B A Stoll
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Insulin-like growth factors: the unrecognised oncogenes.

Authors:  B R Westley; F E May
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

View more
  13 in total

1.  Reduction of dietary glycaemic load modifies the expression of microRNA potentially associated with energy balance and cancer pathways in pre-menopausal women.

Authors:  Susan E McCann; Song Liu; Dan Wang; Jie Shen; Qiang Hu; Chi-Chen Hong; Vicky A Newman; Hua Zhao
Journal:  Br J Nutr       Date:  2012-05-30       Impact factor: 3.718

2.  Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer.

Authors:  Mustafa Akker; Sibel Güldiken; Tammam Sipahi; Orkide Palabıyık; Ayhan Tosunoğlu; Özlem Çelik; Nermin Tunçbilek; Atakan Sezer; Necdet Süt
Journal:  Mol Biol Rep       Date:  2014-02-07       Impact factor: 2.316

3.  PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer.

Authors:  A Belfiore; M Genua; R Malaguarnera
Journal:  PPAR Res       Date:  2009-07-07       Impact factor: 4.964

4.  IGF and insulin receptor signaling in breast cancer.

Authors:  Antonino Belfiore; Francesco Frasca
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-19       Impact factor: 2.673

5.  Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer.

Authors:  Harriet Johansson; Sara Gandini; Aliana Guerrieri-Gonzaga; Simona Iodice; Massimiliano Ruscica; Bernardo Bonanni; Marcella Gulisano; Paolo Magni; Franca Formelli; Andrea Decensi
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

6.  Therapeutic implications of targeting energy metabolism in breast cancer.

Authors:  Meena K Sakharkar; Babita Shashni; Karun Sharma; Sarinder K Dhillon; Prabhakar R Ranjekar; Kishore R Sakharkar
Journal:  PPAR Res       Date:  2013-02-03       Impact factor: 4.964

7.  The insulin receptor: a new target for cancer therapy.

Authors:  Roberta Malaguarnera; Antonino Belfiore
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-06       Impact factor: 5.555

8.  Cross-Sectional Associations between Body Size, Circulating Sex-Steroid Hormones and IGF Components among Healthy Chinese Women.

Authors:  Lauren E McCullough; Erline E Miller; Qiong Wang; Jia-Yuan Li; Li Liu; Hui Li; Jing Zhang; Jennifer S Smith
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

9.  The insulin and igf-I pathway in endocrine glands carcinogenesis.

Authors:  Roberta Malaguarnera; Alaide Morcavallo; Antonino Belfiore
Journal:  J Oncol       Date:  2012-08-08       Impact factor: 4.375

10.  Examining the relationship between diet-induced acidosis and cancer.

Authors:  Ian Forrest Robey
Journal:  Nutr Metab (Lond)       Date:  2012-08-01       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.